Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) Updates Claim of a Healthy Pipeline
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) lately gave an update on its pipeline. Isis Pharmaclaims of a healthy pipeline. The firm thinks 5 of its pipeline candidates can get acceptance within the...
View ArticleBiogen Idec (NASDAQ:BIIB) Post 2.7% Drop in Fiscal Q4 on Higher Outlays –...
Biogen Idec Inc (NASDAQ:BIIB) reported fiscal Q4 earnings moved down 2.7% as the company’s attempts to increase its output pipeline masked its revenue expansion. The biotechnology company also...
View ArticleMerck (NYSE:MRK) Shatters Profit Guidance for Fiscal Year 2013; Fiscal Q4 Net...
The Whitehouse Station, New Jersey-based Merck & Co, Inc’s (NYSE:MRK) current year profit forecasts tumbles as generic rivalry to its best selling medicine Singular will damage results. The drug...
View ArticleGilead Sciences (NASDAQ:GILD) Seeks Strenght in Blood Cancer Drugs; Spend...
Gilead Sciences, Inc (NASDAQ:GILD) has invested $1.2 billion in 2 years to acquire blood cancer medicines. The Foster City, California based Gilead Sciences is the world’s biggest producer of HIV...
View ArticleHUMHumana (NYSE:HUM) Declares fiscal Q4 Results; Earnings Hikes 3.5% – HUM,...
Humana Inc (NYSE:HUM) announced on Monday that fiscal Q4 earnings moved down 3.5 percent as higher coverage outlays masked firm’s revenue expansion from higher membership. The health-care company done...
View ArticleGilead Sciences (NASDAQ:GILD) Completes Acquisition of YM BioSciences (YMI) –...
Gilead Sciences, Inc (NASDAQ:GILD) reported on Friday that it has done it’s almost $510 million purchase of Mississauga, Canada-based YM BioSciences Inc (USA) (NYSEAMEX:YMI). Biopharmaceuticals firm...
View ArticleHealth Perfect Stocks Alert; Gilead Sciences Inc. (NASDAQ:GILD) and Johnson &...
Johnson & Johnson’s (NYSE:JNJ) Janssen Research & Development LLC reported that the US Food and Drug Administration once more refused the acceptance of its blood thinner Xarelto for patients...
View ArticleKey Movers in Healthcare Sector: Gilead Sciences (NASDAQ:GILD), Pfizer...
Investors responded positively to the healthcare stocks on Thursday. Key movement were monitored in Repros Therapeutics Inc (NASDAQ:RPRX) and Neurocrine Biosciences, Inc (NASDAQ:NBIX) on percentage...
View ArticleInvestors Watch List: First Solar (NASDAQ:FSLR), Gilead Sciences (NASDAQ:GILD)
First Solar, Inc (NASDAQ:FSLR) announced on Tuesday that it projects fiscal year 2013 revenue and earnings that surpassed analysts’ estimates amid a rosy guidance for its power-plant development unit,...
View ArticleHealthcare Sector News Buzz: Mylan (NASDAQ:MYL), Gilead Sciences...
Investors responded positively to the healthcare stocks on Thursday. Key movement were observed in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) and Brookdale Senior Living, Inc (NYSE:BKD) on percentage...
View Article
More Pages to Explore .....